Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 36.96% is 199% above its 5-year average of 12.34%, near the high end of its 5-year range (6.00%–36.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.69% above its 12-month average of 26.08%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 36.96%.
DEBT TO ASSETS RATIO
36.96%
DEBT TO ASSETS RATIO AVG TTM
26.08%
DEBT TO ASSETS RATIO AVG 3Y
17.40%
DEBT TO ASSETS RATIO AVG 5Y
12.34%
DEBT TO ASSETS RATIO AVG 10Y
13.84%
DEBT TO ASSETS RATIO AVG 15Y
9.42%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+41.69%
CURRENT VS 3Y AVG
+112.45%
CURRENT VS 5Y AVG
+199.40%
CURRENT VS 10Y AVG
+167.10%
CURRENT VS 15Y AVG
+292.55%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 465 covered companies
CURRENT VS SECTOR MEDIAN
+33499.86%
vs the sector median at left
CollPlant Biotechnologies Ltd.
Market Cap
$4.42M
Debt to Assets Ratio
36.96%
TTM Avg
26.08%
3Y Avg
17.40%
5Y Avg
12.34%
Market Cap
$4.41M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.46M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.79M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.94M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.96M
Debt to Assets Ratio
0.49%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.42M | 36.96% | 26.08% | 17.40% | 12.34% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 0.06% | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 0.00% | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | 0.09% | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.18M | 0.00% | N/A | N/A | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | 0.00% | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 0.00% | N/A | N/A | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | 0.29% | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | 0.49% | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | 0.25% | N/A | N/A | N/A |
Debt/Assets
37.0%
Debt/Equity
0.90
Current Ratio
1.57
Interest Coverage
-765.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 36.96% |
| 2026-03-31 | 28.85% |
| 2025-12-31 | 26.39% |
| 2025-09-30 | 20.87% |
| 2025-06-30 | 17.36% |
| 2025-03-31 | 16.52% |
| 2024-12-31 | 16.47% |
| 2024-09-30 | 14.50% |
| 2024-06-30 | 12.74% |
| 2024-03-31 | 9.97% |
| 2023-12-31 | 9.26% |
| 2023-09-30 | 8.25% |
| 2023-06-30 | 8.05% |
| 2023-03-31 | 9.72% |
| 2022-12-31 | 7.71% |
| 2022-09-30 | 7.16% |
| 2022-06-30 | 6.81% |
| 2022-03-31 | 7.04% |
| 2021-12-31 | 7.04% |
| 2021-09-30 | 6.21% |
| 2021-06-30 | 6.00% |
| 2021-03-31 | 5.76% |
| 2020-12-31 | 31.25% |
| 2020-09-30 | 25.87% |
| 2020-06-30 | 31.12% |
| 2020-03-31 | 26.40% |
| 2019-12-31 | 33.65% |
| 2019-09-30 | 70.37% |
| 2019-06-30 | 38.17% |
| 2019-03-31 | 30.10% |
| 2018-12-31 | 0.49% |
| 2018-09-30 | 0.84% |
| 2018-06-30 | 0.92% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 45.07% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
